FDA Advisory Committees - FDA Center for Drug Evaluation and Research (CDER) - Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

Upcoming Meetings


Past Meetings

Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

CRDAC reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cardiovascular and renal disorders and makes appropriate recommendations to the Commissioner of Food and Drugs.

FDA Committee Website